Overall rank by patents
#44,635
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView Foreign Corporation
Aspide Medical
USPTO PatentsView assignee record - 5 granted patents across 4 technology areas, active 2015–2018. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE).
5
Total patents granted
4
CPC technology areas
6.6
Avg claims per patent
-100%
5-year filing velocity
The verdict
Aspide holds 5 US patents across 4 technology areas, rank #44,635 of 50,000 tracked assignees.
- #44,635
- of 50,000 US assignees by volume
- Top 96%
- by Innovation Score (17.2/100)
- 6.6
- avg claims per patent
- -100%
- filing velocity, last 5 yrs
Portfolio overview
Aspide Medical has been granted 5 US utility patents between 2015 and 2018, placing Aspide Medical at rank #44,635 across all assignees tracked by PlainPatent. This portfolio spans 4 distinct Cooperative Patent Classification (CPC) subclasses, averaging 6.6 claims per patent with primary concentration in A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE). As a Foreign Corporation, Aspide Medical is one of the more focused assignees in the PatentsView dataset. By volume, Aspide sits between ASIA Vital Components (shen Zhen) Co., Ltd. (5 patents, rank #44,631) and Associated Hygienic Products Llc (5 patents, rank #44,639) - the closest US assignees by grant volume. The composite Innovation Score of 17.2/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 0 grants, compared with 5 in the 2015–2019 window, a -100% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Aspide Medical's 6.6 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while specialization in 4 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Aspide Medical against peers pursuing similar technology classes.
Who files at Aspide's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- ASIA Vital Compon…
ASIA VITAL COMPONENTS (SHEN ZHEN) CO., LTD.
5 patents
- Askey Technology…
ASKEY TECHNOLOGY (JIANGSU) LTD.
5 patents
- ASML US
ASML US, LLC
5 patents
- Aspendam
ASPENDAM, LLC
5 patents
- Aspire FOOD Group…
ASPIRE FOOD GROUP USA INC.
5 patents
- ASSA Abloy Fenest…
ASSA ABLOY FENESTRATION, LLC
5 patents
- ASSA Abloy Korea
ASSA ABLOY Korea
5 patents
- Associated Hygien…
ASSOCIATED HYGIENIC PRODUCTS LLC
5 patents
- Aspide Medical ◀
ASPIDE MEDICAL
5 patents
What this shows Aspide holds 5 patents at rank #44,635, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Aspide
By rank, the assignees closest to #44,635 in granted patent volume.
- ASIA Vital Components (shen Zhen) Co., Ltd. #44,631 · 5 patents
- Askey Technology (jiangsu) Ltd. #44,632 · 5 patents
- ASML US, Llc #44,633 · 5 patents
- Aspendam, Llc #44,634 · 5 patents
- Aspire FOOD Group USA Inc. #44,636 · 5 patents
- ASSA Abloy Fenestration, Llc #44,637 · 5 patents
- ASSA Abloy Korea #44,638 · 5 patents
- Associated Hygienic Products Llc #44,639 · 5 patents
Leaders in A61F (Filters Implantable INTO Blood Vessels)
Other assignees with the most granted patents in Aspide's primary technology class.
- The Procter & Gamble Company 1,426 in class
- Boston Scientific Scimed, Inc. 1,101 in class
- Edwards Lifesciences Corporation 1,101 in class
- Depuy Synthes Products, Inc. 851 in class
- Globus Medical, Inc. 752 in class
- COOK Medical Technologies Llc 700 in class
- Smith & Nephew, Inc. 541 in class
- Covidien Lp 528 in class
Aspide's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
17 Top 96% higher than 4% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 40.0% |
| 2016 | 2 | 40.0% |
| 2018 | 1 | 20.0% |
Which technologies does Aspide Medical patent most?
Top 4 of 4 technology areas
Patent Moat Analysis
Portfolio Volume Light
Tech Breadth Specialized
Claim Depth Simple
Velocity Declining
Frequently Asked Questions
How many patents does Aspide Medical hold?
Aspide Medical holds 5 US granted patents filed between 2015 and 2018, spanning 4 technology areas.
What is Aspide Medical's Innovation Score?
Aspide Medical has an Innovation Score of 17.2 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Aspide Medical focus on?
Aspide Medical's top technology area is A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS) with 2 patents. The company has filed patents in 4 CPC subclasses total.
Is Aspide Medical's patent filing rate increasing or decreasing?
Aspide Medical's recent filing velocity is -100% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for Aspide Medical's patents?
Aspide Medical's patents average 6.6 claims each. This is relatively simple claim structure, typical for focused inventions.
How is the Aspide Medical patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
How to use this portfolio
Aspide's 5 grants land it in the top 96% by Innovation Score, but volume alone doesn't tell you where the strength sits.
- Read that count against the largest US assignees before treating it as dominance - Aspide ranks #44,635 of 50,000. Top 50 holders
- Most of this portfolio concentrates in A61F - see who else leads that technology area. A61F leaders
- Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.